Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingcong Ma

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Breast (Edinburgh, Scotland)|April 28, 2023
Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar scoreCong Feng, Yinbin Zhang, Fei Wu, et al.
American Journal of Cancer Research|July 16, 2025
Erratum: Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarizationXixi Zhao, Jingkun Qu, Xu Liu, et al.
Oncotarget|April 19, 2017
Association of two microRNA polymorphisms miR-27 rs895819 and miR-423 rs6505162 with the risk of cancerHong Zhang, Yafei Zhang, Xixi Zhao, et al.
American Journal of Cancer Research|September 14, 2018
Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarizationXixi Zhao, Jingkun Qu, Xu Liu, et al.
Cancer Cell International|July 3, 2025
Bio-engineered microRNA-7 effectively interferes with the Akt3/p53 axis to suppress human non-small cell lung cancerQian Huang, Xiaohua Chu, Chaofei Yang, et al.
International Journal of Pharmaceutics|December 1, 2025
Advanced strategies based on nanomedicine for Liver fibrosis treatmentLu Zhang, Tingting Liu, Huan Shen, et al.
Arthritis Research & Therapy|September 15, 2023
Causal associations of Sjögren's syndrome with cancers: a two-sample Mendelian randomization studyYiwei Jia, Peizhuo Yao, Jia Li, et al.
Japanese Journal of Clinical Oncology|May 19, 2020
Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in ChinaXiaoyao Zhao, Yinbin Zhang, Xingcong Ma, et al.
Translational Oncology|December 15, 2024
Prognostic prediction for inflammatory breast cancer patients using random survival forest modelingYiwei Jia, Chaofan Li, Cong Feng, et al.
Journal for Immunotherapy of Cancer|September 3, 2025
Preclinical evaluation of antitumor activity and toxicity of TROP2-specific CAR-T cells for treatment of triple-negative breast cancerShiyu Sun, Xiaojia Wang, Yongchen Chen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Breast (Edinburgh, Scotland)|April 28, 2023
Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar scoreCong Feng, Yinbin Zhang, Fei Wu, et al.
American Journal of Cancer Research|July 16, 2025
Erratum: Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarizationXixi Zhao, Jingkun Qu, Xu Liu, et al.
Oncotarget|April 19, 2017
Association of two microRNA polymorphisms miR-27 rs895819 and miR-423 rs6505162 with the risk of cancerHong Zhang, Yafei Zhang, Xixi Zhao, et al.
American Journal of Cancer Research|September 14, 2018
Baicalein suppress EMT of breast cancer by mediating tumor-associated macrophages polarizationXixi Zhao, Jingkun Qu, Xu Liu, et al.
Cancer Cell International|July 3, 2025
Bio-engineered microRNA-7 effectively interferes with the Akt3/p53 axis to suppress human non-small cell lung cancerQian Huang, Xiaohua Chu, Chaofei Yang, et al.
International Journal of Pharmaceutics|December 1, 2025
Advanced strategies based on nanomedicine for Liver fibrosis treatmentLu Zhang, Tingting Liu, Huan Shen, et al.
Arthritis Research & Therapy|September 15, 2023
Causal associations of Sjögren's syndrome with cancers: a two-sample Mendelian randomization studyYiwei Jia, Peizhuo Yao, Jia Li, et al.
Japanese Journal of Clinical Oncology|May 19, 2020
Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in ChinaXiaoyao Zhao, Yinbin Zhang, Xingcong Ma, et al.
Translational Oncology|December 15, 2024
Prognostic prediction for inflammatory breast cancer patients using random survival forest modelingYiwei Jia, Chaofan Li, Cong Feng, et al.
Journal for Immunotherapy of Cancer|September 3, 2025
Preclinical evaluation of antitumor activity and toxicity of TROP2-specific CAR-T cells for treatment of triple-negative breast cancerShiyu Sun, Xiaojia Wang, Yongchen Chen, et al.
Pageof 3